Sotac Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 19, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	1,210	1,337	-	-	-	-
Enterprise Value	1,522	1,578	-	-	-	-
Last Close Price	109.50	121.00	-	-	-	-
PE Ratio	27.14	31.23	-	-	-	-
PS Ratio	1.15	1.29	-	-	-	-
PB Ratio	2.77	2.71	-	-	-	-
P/TBV Ratio	3.23	3.08	-	-	-	-
EV/Sales Ratio	1.45	1.52	-	-	-	-
EV/EBITDA Ratio	17.47	17.90	-	-	-	-
EV/EBIT Ratio	27.59	27.59	-	-	-	-
Debt / Equity Ratio	0.55	0.50	1.12	1.12	6.67	2.85
Debt / EBITDA Ratio	3.21	2.82	2.90	0.93	11.78	7.22
Debt / FCF Ratio	-	-	-	2.60	-	-
Asset Turnover	0.98	1.16	1.42	2.09	1.50	-
Inventory Turnover	4.92	5.03	6.02	10.95	11.01	-
Quick Ratio	0.54	0.69	0.55	0.45	0.31	0.41
Current Ratio	1.12	1.39	1.03	0.94	0.76	0.71
Return on Equity (ROE)	8.46%	10.37%	17.38%	62.65%	-64.97%	-
Return on Assets (ROA)	3.21%	4.00%	6.10%	12.24%	-2.19%	-
Return on Capital (ROIC)	4.69%	6.17%	11.92%	25.41%	-3.76%	-
Earnings Yield	3.69%	3.20%	-	-	-	-
FCF Yield	-5.03%	-25.36%	-	-	-	-
Payout Ratio	0.00%	-	-	15.98%	-	-
Buyback Yield / Dilution	-36.35%	-	-	-132.16%	-
Total Shareholder Return	-36.35%	-	-	-132.16%	-

Source: S&P Capital IQ. Standard template. Financial Sources.